Orally Active Microtubule-Targeting Agent, MPT0B271, for the Treatment of Human Non-Small Cell Lung Cancer, Alone and in Combination With Erlotinib

Cell Death and Disease - United Kingdom
doi 10.1038/cddis.2014.128
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC